Literature DB >> 23216060

Catalytic detoxification of nerve agent and pesticide organophosphates by butyrylcholinesterase assisted with non-pyridinium oximes.

Zoran Radić1, Trevor Dale, Zrinka Kovarik, Suzana Berend, Edzna Garcia, Limin Zhang, Gabriel Amitai, Carol Green, Božica Radić, Brendan M Duggan, Dariush Ajami, Julius Rebek, Palmer Taylor.   

Abstract

In the present paper we show a comprehensive in vitro, ex vivo and in vivo study on hydrolytic detoxification of nerve agent and pesticide OPs (organophosphates) catalysed by purified hBChE (human butyrylcholinesterase) in combination with novel non-pyridinium oxime reactivators. We identified TAB2OH (2-trimethylammonio-6-hydroxybenzaldehyde oxime) as an efficient reactivator of OP-hBChE conjugates formed by the nerve agents VX and cyclosarin, and the pesticide paraoxon. It was also functional in reactivation of sarin- and tabun-inhibited hBChE. A 3-5-fold enhancement of in vitro reactivation of VX-, cyclosarin- and paraoxon-inhibited hBChE was observed when compared with the commonly used N-methylpyridinium aldoxime reactivator, 2PAM (2-pyridinealdoxime methiodide). Kinetic analysis showed that the enhancement resulted from improved molecular recognition of corresponding OP-hBChE conjugates by TAB2OH. The unique features of TAB2OH stem from an exocyclic quaternary nitrogen and a hydroxy group, both ortho to an oxime group on a benzene ring. pH-dependences reveal participation of the hydroxy group (pKa=7.6) forming an additional ionizing nucleophile to potentiate the oxime (pKa=10) at physiological pH. The TAB2OH protective indices in therapy of sarin- and paraoxon-exposed mice were enhanced by 30-60% when they were treated with a combination of TAB2OH and sub-stoichiometric hBChE. The results of the present study establish that oxime-assisted catalysis is feasible for OP bioscavenging.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23216060      PMCID: PMC4772673          DOI: 10.1042/BJ20121612

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Criteria for Linear Equivalence.

Authors:  A Weil
Journal:  Proc Natl Acad Sci U S A       Date:  1952-03       Impact factor: 11.205

2.  Exposure to tri-o-cresyl phosphate detected in jet airplane passengers.

Authors:  Mariya Liyasova; Bin Li; Lawrence M Schopfer; Florian Nachon; Patrick Masson; Clement E Furlong; Oksana Lockridge
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-24       Impact factor: 4.219

3.  Mechanism of oxime reactivation of acetylcholinesterase analyzed by chirality and mutagenesis.

Authors:  L Wong; Z Radic; R J Brüggemann; N Hosea; H A Berman; P Taylor
Journal:  Biochemistry       Date:  2000-05-16       Impact factor: 3.162

4.  In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.

Authors:  Maja Calić; Ana Lucić Vrdoljak; Bozica Radić; Dubravko Jelić; Daniel Jun; Kamil Kuca; Zrinka Kovarik
Journal:  Toxicology       Date:  2005-12-05       Impact factor: 4.221

Review 5.  Role of edrophonium in prevention of the re-inhibition of acetylcholinesterase by phosphorylated oxime.

Authors:  C Luo; A Saxena; Y Ashani; H Leader; Z Radić; P Taylor; B P Doctor
Journal:  Chem Biol Interact       Date:  1999-05-14       Impact factor: 5.192

6.  In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia) as a potential nerve agent bioscavenger.

Authors:  D M Cerasoli; E M Griffiths; B P Doctor; A Saxena; J M Fedorko; N H Greig; Q S Yu; Y Huang; H Wilgus; C N Karatzas; I Koplovitz; D E Lenz
Journal:  Chem Biol Interact       Date:  2005-12-15       Impact factor: 5.192

Review 7.  Patterns and problems of deliberate self-poisoning in the developing world.

Authors:  M Eddleston
Journal:  QJM       Date:  2000-11

8.  Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.

Authors:  Gabi Amitai; Rellie Adani; Guy Yacov; Shelly Yishay; Shai Teitlboim; Liat Tveria; Osnat Limanovich; Moshe Kushnir; Haim Meshulam
Journal:  Toxicology       Date:  2006-10-13       Impact factor: 4.221

9.  Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice.

Authors:  Y Ashani; S Shapira; D Levy; A D Wolfe; B P Doctor; L Raveh
Journal:  Biochem Pharmacol       Date:  1991-01-01       Impact factor: 5.858

Review 10.  Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: implications for public protection.

Authors:  N Munro
Journal:  Environ Health Perspect       Date:  1994-01       Impact factor: 9.031

View more
  18 in total

1.  Catalytic Soman Scavenging by the Y337A/F338A Acetylcholinesterase Mutant Assisted with Novel Site-Directed Aldoximes.

Authors:  Zrinka Kovarik; Nikolina Maček Hrvat; Maja Katalinić; Rakesh K Sit; Alexander Paradyse; Suzana Žunec; Kamil Musilek; Valery V Fokin; Palmer Taylor; Zoran Radić
Journal:  Chem Res Toxicol       Date:  2015-04-16       Impact factor: 3.739

2.  HI-6 assisted catalytic scavenging of VX by acetylcholinesterase choline binding site mutants.

Authors:  Nikolina Maček Hrvat; Suzana Žunec; Palmer Taylor; Zoran Radić; Zrinka Kovarik
Journal:  Chem Biol Interact       Date:  2016-04-12       Impact factor: 5.192

3.  Non-quaternary oximes detoxify nerve agents and reactivate nerve agent-inhibited human butyrylcholinesterase.

Authors:  Gabriel Amitai; Alexander Plotnikov; Shira Chapman; Shlomi Lazar; Rellie Gez; Dan Loewenthal; Khriesto A Shurrush; Galit Cohen; Leonardo J Solmesky; Haim Barr; Alan J Russell
Journal:  Commun Biol       Date:  2021-05-14

Review 4.  Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review.

Authors:  Mohamed B Abou-Donia; Briana Siracuse; Natasha Gupta; Ashly Sobel Sokol
Journal:  Crit Rev Toxicol       Date:  2016-10-05       Impact factor: 5.635

5.  Evaluating the broad-spectrum efficacy of the acetylcholinesterase oximes reactivators MMB4 DMS, HLö-7 DMS, and 2-PAM Cl against phorate oxon, sarin, and VX in the Hartley guinea pig.

Authors:  Christina M Wilhelm; Thomas H Snider; Michael C Babin; Gennady E Platoff; David A Jett; David T Yeung
Journal:  Neurotoxicology       Date:  2018-07-26       Impact factor: 4.294

6.  A comprehensive evaluation of the efficacy of leading oxime therapies in guinea pigs exposed to organophosphorus chemical warfare agents or pesticides.

Authors:  Christina M Wilhelm; Thomas H Snider; Michael C Babin; David A Jett; Gennady E Platoff; David T Yeung
Journal:  Toxicol Appl Pharmacol       Date:  2014-10-31       Impact factor: 4.219

Review 7.  Resurrection and Reactivation of Acetylcholinesterase and Butyrylcholinesterase.

Authors:  Andrew J Franjesevic; Sydney B Sillart; Jeremy M Beck; Shubham Vyas; Christopher S Callam; Christopher M Hadad
Journal:  Chemistry       Date:  2019-02-13       Impact factor: 5.236

8.  On-substrate Enzymatic Reaction to Determine Acetylcholinesterase Activity in Whole Blood by Paper Spray Mass Spectrometry.

Authors:  Daniel O Carmany; Phillip M Mach; Gabrielle M Rizzo; Elizabeth S Dhummakupt; Ethan M McBride; Jennifer W Sekowski; Bernard Benton; Paul S Demond; Michael W Busch; Trevor Glaros
Journal:  J Am Soc Mass Spectrom       Date:  2018-10-02       Impact factor: 3.109

9.  Imidazole aldoximes effective in assisting butyrylcholinesterase catalysis of organophosphate detoxification.

Authors:  Rakesh K Sit; Valery V Fokin; Gabriel Amitai; K Barry Sharpless; Palmer Taylor; Zoran Radić
Journal:  J Med Chem       Date:  2014-02-07       Impact factor: 7.446

10.  Chemical Polysialylation and In Vivo Tetramerization Improve Pharmacokinetic Characteristics of Recombinant Human Butyrylcholinesterase-Based Bioscavengers.

Authors:  S S Terekhov; I V Smirnov; O G Shamborant; T V Bobik; D G Ilyushin; A N Murashev; I A Dyachenko; V A Palikov; V D Knorre; A A Belogurov; N A Ponomarenko; E S Kuzina; D D Genkin; P Masson; A G Gabibov
Journal:  Acta Naturae       Date:  2015 Oct-Dec       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.